LAURA R NASH

Allopathic & Osteopathic Physicians|Internal Medicine COLUMBUS, OH NPI 1881990604

General Payments — all program years on this page

$834.29

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $407.55 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $407.5522

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $65.535
2021 $61.884
2022 $144.059
2023 $155.2810
2024 $407.5522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086154033 Bayer Healthcare Pharmaceuticals Inc. $14.67 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096777495 Novo Nordisk Inc $17.02 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101488683 E.R. Squibb & Sons, L.L.C. $19.44 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101488717 E.R. Squibb & Sons, L.L.C. $17.06 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105101689 ABBVIE INC. $25.87 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105101691 ABBVIE INC. $19.44 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105101693 ABBVIE INC. $20.69 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116260260 GlaxoSmithKline, LLC. $17.00 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116592528 GlaxoSmithKline, LLC. $19.37 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118215207 Boehringer Ingelheim Pharmaceuticals, Inc. $17.79 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125322249 Abbott Laboratories $23.60 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125322251 Abbott Laboratories $14.94 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125322253 Abbott Laboratories $17.11 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130990125 PFIZER INC. $23.62 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131158438 PFIZER INC. $15.40 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131884839 PFIZER INC. $15.23 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131935324 PFIZER INC. $16.91 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132088063 PFIZER INC. $21.24 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135124916 Lilly USA, LLC $19.72 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135134546 Lilly USA, LLC $16.94 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135147296 Lilly USA, LLC $17.62 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141688082 Merck Sharp & Dohme LLC $16.87 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.